Salvage treatment of multi-refractory primary immune thrombocytopenia with CD19 CAR T cells - The Lancet thelancet.com/journals/lance…
Amit Agarwal retweeted
We used #GPT4 to greatly simplify medical consent forms for patients in new @NEJM_AI paper ai.nejm.org/stoken/default+d… Our #LLM simplified forms are now used in the largest health system in Rhode Island.
Medical documents like consent forms are often hard to understand--great use case for LLM. We had medical + legal experts review the simplified forms to ensure accuracy.
Great job led by @RohaidAliMD Fatima Mirza @oliverytang @IDavidConnolly and wonderful collaborators! 🚀
Amit Agarwal retweeted
In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91
#AHA23 @AHAScience
Amit Agarwal retweeted
Diwali honors the victory of light over darkness, good over evil, and knowledge over ignorance.
Wishing all my friends who observe #Diwali and to all the world - a victory of light, good and knowledge during this dark & divisive time.
#Diwali2023 #Deepavali
Amit Agarwal retweeted
Deletion of the inhibitory co-receptor CTLA4 enhances and invigorates chimeric antigen receptor T cells #immunotherapy #CARTCell #tcellrx
cell.com/immunity/fulltext/S…
Excited to share my Ph.D. work in @carlhjune lab showing uninhibited CD28 co-stimulation via CTLA4 disruption invigorates dysfunctional CART cells
doi.org/10.1016/j.immuni.202…
Such a stellar group- very well deserved!!!
Congratulations to this year's award recipients! Join us on Thursday, September 28 at 9:00 am during #IMS23 for the award ceremony.
I remember this one like yesterday... this is one of my favorite @sachin_rt ODI innings... and there are many!!!
thecricketmonthly.com/story/…
144
Amit Agarwal retweeted
The first dosing of a patient in the U.S. with a base-edited therapeutic has taken place. Congratulations to the @BeamTx team on achieving this milestone. 🍻
First patient dosed with Beam-201! 💫 globenewswire.com/news-relea…
Amit Agarwal retweeted
Original Article: Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma nej.md/3sDc40Z
Science behind the Study: Mezigdomide and Multiple Myeloma nej.md/3R2XaeK
#MedTwitter Is there an ICD code for this?
People under 50 kilograms banned from the streets in China due to Typhoon Saola
teapawt.org/daktilock/status/16977…
1
213
Amit Agarwal retweeted
#CART therapy for AML is challenged by shared antigens with HSPCs... 2 papers out in the past 24 hours show us a solution to this problem...
nature.com/articles/s41586-0…
#CART therapy for AML is challenged by shared antigens with HSPCs... 2 papers out in the past 24 hours show us a solution to this problem...
nature.com/articles/s41586-0…
Amazing work- congratulations Nizar!!!
Thrilled to share our work @NatureMedicine, led by the very talented @hollyleeYJ, with Dr Paola Neri, @FrancescoMaura4, @RascheLeo, @PedalheadPHX nature.com/articles/s41591-0… #msmm @UCalgary @UCalgaryMed @Charb_Cancer (1/15)
3
508
Wow… proud moment!!!
Chandrayaan-3 Mission:
'India🇮🇳,
I reached my destination
and you too!'
: Chandrayaan-3
@Chandrayaan3 has successfully
soft-landed on the moon 🌖!.
Congratulations, India🇮🇳!
#Chandrayaan_3
#Chandrayaan3Landing #Chandrayaan3 #MoonLanding #india #VikramLander
3
447
























